Growth Metrics

Sanara MedTech (SMTI) Current Deferred Revenue (2017 - 2018)

Sanara MedTech posted quarterly Current Deferred Revenue of $10474.0 for Q4 2018, down 24.76% year-on-year from $13920.0 in Q4 2017, and down 13.73% on a QoQ basis from $12141.0 in Q3 2018.

Sanara MedTech (SMTI) has 2 years of Current Deferred Revenue data on file, last reported at $10474.0 in Q4 2018.

  • For the quarter ending Q4 2018, Current Deferred Revenue fell 24.76% year-over-year to $10474.0; the trailing twelve-month figure through Dec 2018 stood at $10474.0 (down 24.76% YoY), and the FY2018 full-year result was $10474.0, down 24.76% from the prior year.
  • Current Deferred Revenue for Q4 2018 stood at $10474.0, down from $12141.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $13920.0 in Q4 2017 and bottomed at $10474.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Sanara MedTech 203.69 Mn 190.09 Mn 25.87 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 10,474.00
Sep 30, 2018 12,141.00
Jun 30, 2018 12,913.00
Mar 31, 2018 13,703.00
Dec 31, 2017 13,920.00